BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15809713)

  • 1. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
    Pantic M; Zimmermann S; Waller CF; Martens UM
    Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
    El Daly H; Martens UM
    Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
    Misawa M; Tauchi T; Sashida G; Nakajima A; Abe K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2002 Nov; 21(5):1087-92. PubMed ID: 12370759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
    Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
    Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
    Beisner J; Dong M; Taetz S; Nafee N; Griese EU; Schaefer U; Lehr CM; Klotz U; Mürdter TE
    Lung Cancer; 2010 Jun; 68(3):346-54. PubMed ID: 19695733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells.
    Guo C; Geverd D; Liao R; Hamad N; Counter CM; Price DT
    J Urol; 2001 Aug; 166(2):694-8. PubMed ID: 11458119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
    Hsu CP; Hsu NY; Lee LW; Ko JL
    Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
    Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
    Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts.
    Swiggers SJ; Nibbeling HA; Zeilemaker A; Kuijpers MA; Mattern KA; Zijlmans JM
    Exp Cell Res; 2004 Jul; 297(2):434-43. PubMed ID: 15212946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
    Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
    Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.